1887
Preview this article:
Zoom in
Zoomout

High-level ciprofloxacin resistance in serotype Typhi in India, Page 1 of 1

| /docserver/preview/fulltext/jmm/54/10/JMM5410.999-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45966-0
2005-10-01
2019-11-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/10/JM541017.html?itemId=/content/journal/jmm/10.1099/jmm.0.45966-0&mimeType=html&fmt=ahah

References

  1. Aarestrup, F. M., Molbak, K. & Threlfall, E. J. ( 2003;). Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 47, 827–829.[CrossRef]
    [Google Scholar]
  2. Brown, J. C., Shanahan, P. M., Jesudason, M. V., Thomson, C. J. & Amyes S. G. ( 1996;). Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India. J Antimicrob Chemother 37, 891–900.[CrossRef]
    [Google Scholar]
  3. Eykyn, S. J. & Williams, H. ( 1987;). Treatment of multiresistant Salmonella typhi with oral ciprofloxacin. Lancet ii, 1407–1408.
    [Google Scholar]
  4. Harish, B. N., Madhulika, U. & Parija, S. C. ( 2004;). Isolated high-level ciprofloxacin resistance in Salmonella enterica subsp.enterica serotype Paratyphi A. J Med Microbiol 53, 819. 819.[CrossRef]
    [Google Scholar]
  5. Hirose, K., Hashimoto, A., Tamura, K., Kawamura, Y., Ezaki, T., Sagara, H. & Watanabe, H. ( 2002;). DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A. Antimicrob Agents Chemother 46, 3249–3252.[CrossRef]
    [Google Scholar]
  6. Jesudason, M. V., Malathy, B. & John, J. T. ( 1996;). Trend of increasing minimum inhibitory concentration of ciprofloxacin to Salmonella typhi. Indian J Med Res 103, 247–249.
    [Google Scholar]
  7. Kapil, A., Sood, S., Dash, N. R., Das, B. K. & Seth, P. ( 1999;). Ciprofloxacin in typhoid fever. Lancet 354, 164. 164.
    [Google Scholar]
  8. Kapil, A., Renuka, K. & Das, B. K. ( 2002;). Nalidixic acid susceptibility test to screen ciprofloxacin resistance in Salmonella typhi. Indian J Med Res 115, 49–54.
    [Google Scholar]
  9. Launay, O., Nguyen Van, J. C., Buu-Hoi, A. & Acar, J. F. ( 1997;). Typhoid fever due to a Salmonella typhi strain of reduced susceptibility to fluoroquinolones. Clin Microbiol Infect 3, 541–544.[CrossRef]
    [Google Scholar]
  10. Mandal, B. K. ( 1991;). Modern treatment of typhoid fever. J Infect 22, 1–4.[CrossRef]
    [Google Scholar]
  11. NCCLS ( 2002;). Performance Standards for Antimicrobial Disc Susceptibility Tests, 7th edn. Approved standard M2-A7. Wayne, PA: NCCLS.
  12. Renuka, K., Kapil, A., Kabra, S. K., Wig, N., Das, B. K., Prasad, V. V., Chaudhry, R. & Seth, P. ( 2004;). Reduced susceptibility to ciprofloxacin and gyrA gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A. Microb Drug Resist 10, 146–153.[CrossRef]
    [Google Scholar]
  13. Sanders, C. C. ( 2001;). Mechanisms responsible for cross-resistance and dichotomous resistance among quinolones. Clin Infect Dis 32, S1–S8.[CrossRef]
    [Google Scholar]
  14. Wain, J., Hoa, N. T. T., Chinh, N. T. & 8 other authors ( 1997;). Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 25, 1404–1410.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45966-0
Loading
/content/journal/jmm/10.1099/jmm.0.45966-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error